Sangamo Therapeutics
SGMO
#8849
Rank
โ‚ฌ0.12 B
Marketcap
0,38ย โ‚ฌ
Share price
-1.98%
Change (1 day)
-78.98%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚ฌ0.12 Billion

As of December 2025 Sangamo Therapeutics has a market cap of โ‚ฌ0.12 Billion. This makes Sangamo Therapeutics the world's 8849th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.12 B-74.87%
2024โ‚ฌ0.51 B488.9%
2023โ‚ฌ87.16 M-81.83%
2022โ‚ฌ0.47 B-50.27%
2021โ‚ฌ0.96 B-46.24%
2020โ‚ฌ1.79 B107.09%
2019โ‚ฌ0.86 B-15.5%
2018โ‚ฌ1.02 B-11.24%
2017โ‚ฌ1.15 B464.13%
2016โ‚ฌ0.20 B-65.14%
2015โ‚ฌ0.58 B-31.98%
2014โ‚ฌ0.86 B37.96%
2013โ‚ฌ0.62 B159.69%
2012โ‚ฌ0.24 B110.08%
2011โ‚ฌ0.11 B-49.34%
2010โ‚ฌ0.22 B21.84%
2009โ‚ฌ0.18 B82.26%
2008โ‚ฌ0.10 B-71.63%
2007โ‚ฌ0.35 B105.1%
2006โ‚ฌ0.17 B68.55%
2005โ‚ฌ0.10 B-6.96%
2004โ‚ฌ0.11 B3.1%
2003โ‚ฌ0.10 B52.19%
2002โ‚ฌ71.23 M-72.49%
2001โ‚ฌ0.25 B-43.52%
2000โ‚ฌ0.45 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Sangamo Therapeutics was reported to be:

โ‚ฌ0.12 Billion
by Nasdaq info icon info icon
โ‚ฌ0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚ฌ127.25 B 98,559.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ44.73 B 34,585.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ145.74 B 112,893.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ21.75 B 16,767.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ14.51 B 11,151.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ434.22 B 336,546.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ8.72 B 6,663.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ213.40 B 165,349.43%๐Ÿ‡บ๐Ÿ‡ธ USA